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SUMMARY: Diverse marine flora and fauna collected from the southwest coast of India was evaluated for its antimicrobial 
potential against shrimp Vibrio and multiresistant human pathogens. In total, 47 species of various taxa of marine organisms 
(29 flora and 18 fauna) were screened for antimicrobial activity. The marine flora includes twenty species of seaweeds, two 
species of mangroves, four species of cyanobacteria and three species of microalgae. The marine fauna comprises three 
species of porifera, twelve species of molluscans, one species of sea urchin, one of sea cucumber and one of cnidarian. The 
organic extractives were tested against five type cultures (Microbial Type Culture Collection) of prominent shrimp Vibrio 
pathogens, including V. parahaemolyticus, V. vulnificus, V. harveyi, V. alcaligenes and V. alginolyticus, and five multire-
sistant clinical pathogens: Staphylococcus aureus, Pseudomonas aeruginosa, Bacillus subtilis, Klebsiella pneumoniae and 
Staphylococcus epidermidis. Among the marine organisms screened, seaweeds showed a broad spectrum of antibacterial 
activity. The highly active seaweed Falkenbergia, a heteromorphic sporophyte of Asparagopsis taxiformis (Delile) Tre-
visan, was evaluated further to purify the active compounds using different chromatographic systems, including reverse 
phase HPLC and GC-MS. The analysis revealed that the most abundant metabolites are oleic acid (51.33%) followed by 
n-hexadecanoic acid (42.87%). 
Keywords: antibacterial activity, Falkenbergia-phase, sea urchin, cyanobacteria, sea cucumber, microalgae, seaweeds.
RESUMEN: Potencial de los antimicrobianos de los organismos marinos de la costa sureste de la India frente 
a patógenos multirresistentes del camarón y humanos. – A muestras de flora y fauna marina diversas recogidas de la 
costa suroeste de la India se les evaluó su potencial antimicrobiano frente a Vibrios patógenos de camarón y multirresistentes 
humanos. En total fueron seleccionadas 47 especies de diferentes taxones de organismos marinos (29 de flora y 18 de fauna) 
para evaluar la actividad antimicrobiana. La flora marina incluía veinte especies de algas marinas, dos de manglares, cuatro 
de cianobacterias y tres de microalgas. La fauna marina se componía de tres especies de poríferos, doce de moluscos, una 
de erizo de mar, una de pepinos de mar y una de cnidario. Los extractos orgánicos se probaron en cinco tipos de cultivos 
(microbianos, colección de cultivo tipo) de Vibrio patógeno de camarón incluyendo V. parahaemolyticus, V. vulnificus, V. 
harveyi, V. alcaligenes y V. alginolyticus y cinco patógenos clínicos multirresistentes como Staphylococcus aureus, Pseu-
domonas aeruginosa, Bacillus subtilis, Klebsiella pneumoniae y Staphylococcus epidermidis. Entre los organismos marinos 
examinados, las algas mostraron un amplio espectro de actividad antibacteriana. La gran actividad del alga Falkenbergia, 
- esporofito heteromórfico de Asparagopsis taxiformis (Delile) Trevisan, se evaluó además mediante la purificación de los 
compuestos activos por cromatografía de fase inversa incluyendo HPLC y GC-MS. El análisis reveló que los metabolitos 
más abundantes eran el ácido oleico (51.33%), seguido por el ácido n-hexadecanoico (42.87%).
Palabras clave: actividad antibacteriana, Falkenbergia-fase, erizo de mar, cyanobacteria, pepino de mar, microalgas, algas 
marinas.
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INTRODUCTION
The marine environment (oceans, seas, coastal 
backwaters, estuaries, bays and fjords) is consid-
ered to be a unique source of earth’s biological 
diversity, as it covers 70.8% of earth’s surface and 
comprises more than 200000 described species of 
invertebrates and algae (Winston, 1988), which 
represents only a small percentage of the marine 
biodiversity (Malakoff, 1997). Due to their par-
ticular environment many marine invertebrates 
such as sponges, jelly fish, sea anemones, bryo-
zoans and corals (Bhakuni and Jain, 1990) exhibit 
unique physiological and structural characteris-
tics which enable them to survive in extremes of 
pressure, salinity and temperature. Historically, 
the ocean represents a virtually idyllic resource 
for the discovery of novel bioactive metabolites 
with useful activities (Cragg et al., 1997). Marine 
bioactive compounds, from small to medium mo-
lecular weight, are produced for the purpose of 
greater survivability or fecundity. However, they 
are not essential for the survival of the host organ-
ism. The production of secondary metabolites in 
marine organisms is known to be highly depend-
ent on various bio-geographic conditions (Hay, 
1996). The role and adaptive significance of sec-
ondary metabolites has been a topic of debate for a 
long time (Stone and Williams, 1992). According 
to Harper et al. (2001), secondary metabolites are 
adaptive and play a key role in the host’s defence 
against pathogens, parasites, predators, competi-
tors and epibiota. 
With more intensive studies for natural therapies, 
marine-derived products are a promising source for 
the discovery of novel bioactive compounds. Ma-
rine natural products first began to be discovered 
in the late 1970s. Currently a multitude of chemi-
cally unique metabolites have been identified from a 
relatively small part of the biological and chemical 
diversity of the oceans, many of which are endowed 
with pharmacodynamic properties (Ireland et al., 
1993). With the advent of modern technologies, 
various marine animals, such as tunicates, sponges, 
soft corals, sea hares, nudibranchs, bryozoans and 
sea slugs, are being studied for their bioactive com-
pounds (Harvey, 2000). The overall objective of the 
present study is to evaluate organic extractives of 
marine flora and fauna for the potential development 




Eighteen species of sedentary/slow-moving in-
vertebrate, and twenty nine species of micro and 
macroflora were collected from the Kollam coast 
(Thirumullavaram coast) (southwest coast of In-
dia) during the lowest tide (08º54’N and 76º38’E). 
Seaweeds and mangroves were handpicked when 
their abundance was observed (from November to 
April 2008). The samples of sponges, molluscans, 
sea anemones, sea urchins and sea cucumbers were 
collected during the post monsoon season (July to 
September 2008) by snorkelling at a depth of 1 to 
3 m.
Preparation of extracts from marine algae and 
mangroves
The collected samples were transported to the 
laboratory immediately, washed twice with sterile 
seawater to remove epizoones, epiphytes, sand, 
calcareous matter and other adhering detritus mat-
ters. Samples were blotted in between tissue paper 
to dry them. The dried samples were weighed, and 
stored in a sterile ziplap bag at -20ºC until extrac-
tion. Voucher specimens were preserved in 5% (v/v) 
formaldehyde-seawater solution for identification. 
A known weight (5 gm) of tissue was pounded with 
methanol at room temperature, vortexed and filtered 
through double folded muslin cloth, and the filtrate 
was centrifuged (Eppendorf A G, Germany) at 8679 
rpm for 10 min. The supernatant was evaporated to 
solvent free in a rotary vacuum evaporator (Yamato, 
Yamato Scientific, Japan). The gummy extract was 
collected in screw-capped vials and stored at 4ºC. 
The aliquots were prepared with methanol and tested 
for their antimicrobial activity against human and 
shrimp pathogens.
Cyanobacterial biomass production and 
extraction
The cyanobacteria were scraped off rocks and 
transported to the laboratory in Scott Duran bottles 
with 50 ml of sterile seawater. Four cyanobacteria 
belonging to the orders Nostocales and Chroococ-
cales were isolated from the Kollam coast and 
identified by Dr. Panikkar (algologist) from the 
Department of Botany, Sree Narayana College, Kol-
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lam. The cynobacterial biomass was produced in 
Erlenmeyer flasks incubated at 23±2ºC with shaking 
at 60 rpm and 12:12 h photoperiod with 2000 lux 
illumination for 4 weeks. Cells were harvested after 
4 weeks by centrifugation at 5000 rpm and extracted 
as described above.
Microalgal biomass production and extraction
The cultures of identified algal species Cha-
etoceros sp., Isochrysis galbana and Chlorella ma-
rina were grown under constant illumination in f/2 
medium and incubated under a 12:12 h photoperiod 
with 2000 lux illumination at 23±2ºC with shaking 
at 60 rpm. Microalgae were harvested after approxi-
mately a 15-day production period by centrifugation 
at 5000 rpm and the pellets were washed several 
times with sterile water. A known biomass (5 gm) 
was extracted with methanol and the supernatant 
was subjected to bioassays. 
Preparation of extracts from marine fauna
Marine organisms (sponges, sea cucumber, sea 
urchin, sea anemone and molluscan) were washed 
individually with running water, chopped, pulver-
ized into small pieces and extracted with methanol 
as described above.
Fractionation and purification of active 
compounds from the highly active seaweed 
Falkenbergia-phase of A. taxiformis
The methanolic extract of Falkenbergia (10 gm) 
was loaded in a silica gel (60-120 mesh) (Merck, 
USA) column packed with petroleum ether and 
eluted with petroleum ether and ethyl acetate (9:1 
to 1:9 and 100% ethyl acetate) followed by ethyl ac-
etate and methanol (9:1 to 1:9 and 100% methanol) 
to yield seven fractions. Individual fractions were 
collected and tested for antimicrobial activity. 
The fraction with antimicrobial properties was 
further purified by preparative TLC using silica gel 
G as the stationary phase and 1% methanol in dichlo-
romethane as the mobile phase. After the development 
of chromatogram, the resolved spots were analyzed 
by spraying with 50% sulphuric acid for detecting the 
lipophilic compounds. The TLC resolved spots were 
scraped out and eluted with methanol and finally cen-
trifuged at 8819 rpm for 5 min. The supernatant with 
antimicrobial activity was subjected to HPLC (Shi-
madzu Chromatographic System Kyoto, Japan) at 
254 nm absorbance with methanol at a flow rate of 1 
ml/min; head pressure at 25 kgf/cm2. The whole setup 
was maintained at room temperature (25ºC) and the 
resultant major peaks were subjected to GC-MS anal-
ysis. Phycoconstituents were detected using a Hewlett 
Packard 5890 Series II gas chromatographic system 
(Hewlett Packard, Waldbronn, Germany) equipped 
with HP-5971 mass selective detector (MSD, Hewlett 
Packard, Palo Alto, CA, USA), and a capillary column 
(30m × 0.25mm ×0.25mm) was used with helium at a 
1 ml min-1 as a carrier gas. The GC oven temperature 
was kept at 110°C for two minutes, programmed to 
280°C at the rate of 5°C min-1 and kept constant at 
280°C for 10 minutes. The split ratio was adjusted to 
1: 20 and the injection volume was 2 µl. The injection 
and detector temperature was 250°C. The GC-MS 
electron ionization mode was 70 eV. The mass range 
was from m/z 45 to 450 amu. Peak identification was 
carried out using NIST Version 2.0 (2005).
Test microorganisms
To characterize the antimicrobial activity, the 
methanolic extracts were evaluated against a battery 
of shrimp and multiresistant human pathogenic bac-
teria. Antimicrobial activity was determined against 
(i) five species of type cultures (MTCC- Micro-
bial Type Culture Collection) of fish/shrimp Vibrio 
pathogens including V. harveyi (MTCC 3438), V. 
alginolyticus (MTCC 4439), V. vulnificus (MTCC 
1145), V. parahaemolyticus (MTCC 451) and V. 
alcaligenes (MTCC 4442), (ii) five multiresistant 
pathogens obtained from clinical laboratories in-
cluding the gram-positive bacteria Staphylococcus 
aureus, Bacillus subtilis, Staphylococcus epider-
midis and the gram-negative bacteria Pseudomonas 
aeruginosa and Klebsiella pneumoniae. The resist-
ant patterns of these human pathogenic isolates were 
confirmed using selective antibiotics (streptomycin, 
oxytetracycline, ampicillin and erythromycin) in a 
preliminary experiment. The isolates were estab-
lished as multiresistant pathogens and deposited in 
the Marine Bioprospecting Laboratory, Department 
of Microbiology, Bharathidasan University. 
Antimicrobial assay
The antimicrobial assay was carried out follow-
ing the methodology of Selvin and Lipton (2004). 
Briefly, the base layer was prepared with 10 ml 
290 • A. MANILAL et al.
SCI. MAR., 74(2), June 2010, 287-296. ISSN 0214-8358 doi: 10.3989/scimar.2010.74n2287
(1.5%, w/v) of Mueller Hinton agar (Himedia, In-
dia). Five sterile porcelain beads of 5 mm in diame-
ter were placed on the base layer at 60° angles apart. 
The overlaid seed layer was prepared by pouring 15 
ml of media containing 0.2 ml of prepared inoculum 
(~ 0.2 OD at 630 nm). The porcelain beads were re-
moved carefully with sterile forceps. The resultant 
wells were filled with 120 µl of the appropriate algal 
extract. The well with solvent used for dissolution 
was considered the negative control. The assay was 
performed in triplicates of individual Petri dishes. 
The diameter of the inhibition halo after 24 h of 
incubation at 37°C was considered to be indicative 
of bioactivity. The net halo diameter was calculated 
after subtracting the diameter of the well (5 mm). 
Determining the mechanism of antibiosis 
(bacteriostatic or bactericidal)
The minimal inhibitory concentration (MIC) 
was determined by the broth dilution method. The 
96-well microtiter plates were filled with 100 µl 
of the seaweed extract prepared in Mueller-Hinton 
broth (Himedia, India). The microtiter plates were 
incubated at 37°C for 48 h. In each microtiter plate, 
one row was set as a control (without column frac-
tions) and another row was used as standard (chlo-
ramphenicol and nalidixic acid). After incubation, 
the OD was read at 610 nm (Spectronic 20 UV-Vis 
spectrophotometer, Thermo Scientific, Madison, 
WI, USA). MICs were recorded as the lowest con-
centration inhibiting visible growth. To measure 
the minimal bactericidal concentrations (MBC), the 
MIC cultures were plated on fresh Mueller-Hinton 
agar with 5% lysed horse blood and incubated for 24 
h at 37°C. A reduction of at least 90% of the colonies, 
compared with the culture of the initial inoculum of 
the strain, was regarded as evidence of bactericidal 
activity. When the ratio of MBC/MIC was ≤2 the 
active fractions were considered to be bactericidal, 
otherwise they were considered bacteriostatic. If the 




The study area, Kollam coast, spreads over 45 km 
along the southwest coast of India. It has two estuar-
ies, Paravoor and Astamudi, and many incursions of 
fresh water from agriculture runoff. A ubiquitous la-
terite and scattered granite boulder capping over the 
substrate in the intertidal and upper subtidal zones of 
the coast makes it a highly preferred and desirable 
habitat for a wide range of organisms. Although this 
coastal system is extraordinary for its biodiversity 
and hydrological functions, the flora and fauna of 
Table 1. – List of marine organisms collected from the Kollam coast.
Organisms Species
Chlorophyta
 Enteromorpha compressa (Linn.) Nees
 Cladophora albida (Nees) Kuetzing
 Boodlea composita (Harvey) Brand
 Ulva lactuca Linnaeus
 Bryopsis pennata Lamouroux
 Chaetomorpha brachygona Harvey
 Caulerpa parvula Svedelius
 Ulva rigida Agardh
Phaeophyta 
 Chnoospora bicanaliculata Krishnamurthy and Thomas
 Sargassum cinereum Agardh
 Feldmannia columellaris (Boergesen) Islam
 Dictyota adnata (Zanardini)
 Padina tetrasromatica Hauck
 Lobophora variegata (Lamouroux) Womersley ex Oliveira
Rhodophyta
 Gelidium pusillum (Stackhouse) Le Jolis
 Gelidium micropterum Kuetzing
 Laurencia sp.
 Grateloupia filicina (Lamouroux) Agardh
 Portieria horemanii (Lyngbye) Silva
 Falkenbergia- phase of Asparagopsis taxiformis (Delile) Trevisan 
Microalgae
 Chlorella marina (Butcher)
 Isochrysis galbana (Parke)
 Chaetoceros sp.
Mangroves
 Rhizophora apiculata (Blume)
 Avicinia officinalis (Linnaeus)
Cyanobacteria
 Oscillatoria salina (Biswas)
 Phormidium valderianum (Delp.) Gomont
 Calothrix contarenii (Zanardini) Bornet et Flahault
 Synechococcus sp.
Molluscans
 Cypraea tigris (Linne)
 Cypraea vitellus (Linne)
 Tibia curta (Sowerby)
 Conus sp.
 Trochus radiatus (Gmelin)
 Haliotis varia (Linne)
 Turbo bruneus (Roding)
 Strombus sp.
 Bulla ampulla (Linne)
 Mytilus edulis (Linnaeus)
 Patella vulgata (Linnaeus)
 Limnaea sp.
Sea urchin
 Tripneustes gratilla (Linnaeus) 
Sea cucumber




 Callyspongia subarmigera Ridley
 Acanthella elongata Dendy
 Haliclona sp.
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the area have been studied very little, except for the 
algal communities. In the present study, 47 species 
of marine organisms belonging to different flora and 
fauna were recorded. In spite of the diverse floral 
and faunal assemblages, the present study focused 
on the bioactivity of the dominant marine species in 
order to conserve the low intensity species (Table 1 
and Fig. 1).
Overall bioactivity
Of the 47 marine organisms screened, 33 species 
(9 species of fauna and 24 species of flora) showed 
antimicrobial activity in different ranges with re-
spect to the phyla, species and test organisms used. 
Among the active 33 species, the methanolic extract 
of Falkenbergia exhibited the broadest and highest 
antimicrobial activity (Table 2). The highly active 
seaweed, the Falkenbergia-phase of A. taxiformis, 
was fractionated and purified using different chro-
Table 2. – Antimicrobial activity of flora and fauna collected from the Kollam coast.
Marine organisms     Diameter of inhibition zone (mm)   
   Shrimp pathogens*   Multiresistant human pathogens*
 Vv Vp Vh Vac Va Se Pa Bs Kp Sa
E. compressa 16±1.25 9±2.23 12±2.74 17±2.41 8±3.12 0±00 0±00 0±00 8±1.5 0±00
C. albida 10±2.31 7±2.65 8±1.32 10±2.19 7±3.06 0±00 0±00 0±00 0±00 0±00
B. composita 7±3.21 9±2.05 10±1.65 6±2.46 10±1.45 0±00 0±00 0±00 0±00 0±00
B. pennata 5±1.07 4±1.75 0±00 0±00 0±00 0±00 0±00 0±00 0±00 0±00
C. parvula 3±1.52 0±00 0±00 4±0.56 0±00 0±00 0±00 0±00 0±00 0±00
F. columellaris 0±00 3±1.85 0±00 3±1.46 0±00 0±00 0±00 0±00 0±00 0±00
D. adnata 5±1.42 8±2.03 7±1.37 5±1.76 0±00 0±00 0±00 0±00 0±00 0±00
P. tetrasromatica 12±2.67 11±2.06 0±00 0±00 14±2.96 0±00 0±00 8±2.12 0±00 0±00
L. variegata 24±2.21 9±3.23 9±4.23 14±3.25 8±2.22 8±2.26 9±3.24 9±3.63 0±00 8±2.1
G. pusillum 6±1.65 9±2.61 0±00 0±00 7±2.16 0±00 0±00 0±00 0±00 0±00
G. micropterum 0±00 8±1.08 0±00 7±2.62 0±00 0±00 0±00 0±00 0±00 0±00
Laurencia sp. 23±2.05 20±3.56 14±2.46 18±2.85 22±3.46 11±2.56 8±3.75 0±00 0±00 0±00
G. filicina 08±2.16 9±2.75 11±2.79 0±00 8±2.85 0±00 0±00 0±00 0±00 0±00
P. horemanii 7±1.45 0±00 11±2.52 9±2.12 0±00 0±00 0±00 0±00 0±00 0±00
Falkenbergia-phase 31±2.65 28±3.21 26±2.85 33±2.34 32±1.25 21±2.31 19±1.45 23±1.86 15±2.64 21±3.12
C. marina 0±00 5±2.26 0±00 9±3.24 9±2.35 0±00 0±00 0±00 0±00 0±00
I. galbana 0±00 4±2.74 0±00 8±3.26 8±2.46 0±00 0±00 0±00 0±00 0±00
Chaetoceros sp. 4±1.56 7±1.64 5±2.21 10±2.65 12±1.87 0±00 0±00 0±00 0±00 0±00
R. apiculata 14±2.76 0±00 13±3.95 9±2.64 21±2.85 0±00 6±1.86 6±1.96 7±2.64 7±2.45
A. officinalis 0±00 14±2.65 0±00 0±00 15±1.64 0±00 5±2.62 0±00 0±00 0±00
P. valderianum 8±2.64 9±2.31 8±2.08 14±2.45 0±00 9±2.08 0±00 0±00 7±2.9 0±00
C. contarenii 0±00 0±00 7±3.08 9±4.05 0±00 0±00 0±00 0±00 0±00 0±00
Synechococcus sp. 0±00 9±1.78 9±1.95 9±2.68 13±2.45 0±00 0±00 0±00 0±00 0±00
C. tigris  8±3.23 6±2.45 0±00 5±2.780 0±00 0±00 0±00 0±00 0±00 0±00
T. bruneus 0±00 9±3.21 8±1.46 10±1.06 9±2.65 0±00 0±00 8±2.94 0±00 0±00
T. curta 0±00 7±2.33 0±00 8±00 0±0.0 0±00 0±00 0±00 0±00 0±00
Limnaea sp. 8±4.65 0±00 5±2.68 8±2.54 7±3.45 0±00 0±00 7±1.98 0±00 0±00
T. gratilla 0±00 0±00 0±00 11±2.85 8±2.49 0±00 0±00 0±00 0±00 0±00
B. marmorata 11±2.05 0±00 13±2.97 9±3.45 8±3.62 0±00 0±00 0±00 7±2.86 0±00
Anthopleura sp 0±00 8±2.34 0±00 0±00 11±2.15 0±00 0±00 0±00 0±00 0±00
C. subarmigera 8±2.63 0±00 6±2.12 5±2.63 0±00 0±00 0±00 0±00 0±00 0±00
A. elongata 12±2.87 8±3.14 8±2.61 8±2.14 7±3.21 0±00 0±00 0±00 0±00 0±00
Haliclona sp. 17±2.63 9±2.69 0±00 16±1.64 9±2.07 5±3.05 0±00 8±2.34 0±00 8±3.13
*Shrimp pathogens- V. parahaemolyticus (Vp), V. vulnificus (Vv), V. harveyi (Vh), V. alcaligenes (Vac), and V. alginolyticus (Va). MDR 
human pathogens- Staphylococcus aureus (Sa), Pseudomonas aeruginosa (Pa), Bacillus subtilis (Bs), Klebsiella pneumoniae (Kp), and Sta-
phylococcus epidermidis (Se).
Fig. 1. – Map showing the studied area of the Kollam coast (south-
west coast of India) 
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matographic systems including TLC, reverse phase 
HPLC and GC-MS. 
Antibacterial activity of marine flora
Of the 10 bacterial species tested, shrimp patho-
gens were the most sensitive to the methanolic extract 
of the Falkenbergia-phase of A. taxiformis which 
produced mean zones of inhibition ranging between 
26 and 33 mm. Among the shrimp pathogens, V. 
alcaligenes, V. alginolyticus and V. vulnificus were 
the most susceptible species with marked inhibition 
zones (33, 32 and 31 mm respectively) (see Table 4).
The in vitro screening of the red alga Falken-
bergia showed 100% inhibitory activity against all 
the tested shrimp and human pathogens. Moderate 
activity (15 to 23 mm) was observed against mul-
tiresistant clinical pathogens. Of the five tested 
species of clinical pathogens, the gram positive 
bacterium B. subtilis was highly susceptible with an 
inhibition zone of 23 mm. The methanolic extract 
showed moderate activity against another two gram 
positive bacteria, S. epidermidis (21 mm) and S. 
aureus (21 mm). Among the gram negative bacteria 
tested, maximum activity was observed against P. 
aeruginosa (19 mm), whereas K. pneumoniae (15 
mm) appeared to be the less susceptible. Based on 
the present findings, this marine red alga could be a 
potential source of antibiotics for controlling clinical 
and shrimp aquaculture pathogens. 
Marine red algal species from the southwest 
coast of India are recognized for their antimicrobial 
properties (Selvin and Lipton, 2004). The antimi-
crobial activity of Bonnemaisoniales taxa has been 
highlighted previously by several authors (Paul et 
al., 2006; Salvador et al., 2007; El-Baroty et al., 
2007). Nylund et al. (2005) reported that the crude 
organic extract of Bonnemaisonia hamifera inhib-
ited the growth of nine bacteria. Later, the same au-
thor demonstrated that polyhalogenated 2-heptanone 
from this alga, strongly inhibits the colonization 
and growth of numerous marine bacteria (Nylund 
et al., 2008). Another Bonnemaisonialean species, 
Asparagopsis armata, showed remarkable activity 
against some fish pathogenic bacteria (Bansemir et 
al., 2006). The most characteristic algal bioactive 
compounds that have exhibited significant anti-HIV 
activity, according to the various biochemical as-
says designed for chemotherapeutic strategies, are 
sulphated galactans extracted from the seaweed, A. 
taxiformis (Haslin et al., 2001). 
Lobophora variegata appeared to be the second 
most potent brown algae among the flora screened 
for bioactivity. The inhibition was in the range of 8 
to 24 mm against nine species of shrimp and clini-
cal pathogens. This species demonstrated antifungal 
activity against the saprophyte, Dendeyphella salina 
(Puglisi et al., 2007). 
The mangrove taxa, R. apiculata and A. officina-
lis from the southwest coast of India were studied for 
antimicrobial activity for the first time. The inhibi-
tory activity of mangroves against shrimp pathogens 
was found to be promising. The methanolic extracts 
of both mangroves exhibited antimicrobial activity 
against shrimp and human pathogens. R. apiculata 
showed an inhibition range of 7 to 21 mm against 
all the tested pathogens. A. officinalis showed in-
hibitions of 15, 14 and 5 mm against two shrimp 
Vibrios and one species of human clinical pathogen 
respectively. The results of the present study suggest 
that the mangrove extracts can be used as alternate 
medicine for shrimp and human diseases. Bioactiv-
ity of mangroves has already been reported in many 
works (Premnathan et al., 1996; Abeysinghe and 
Wanigatunge, 2006). However, though mangroves 
are potentially active, the exploration of mangroves 
for pharmaceutical compounds is in a preliminary 
screening phase (Bandaranayake, 1998).
Table 2 shows the antimicrobial activity of the 
cyanobacteria analyzed in this study. Isolation of 
bioactive compounds from marine cyanobacteria 
has been reported in several publications during the 
last few decades (Falch, 1996; Papke et al., 1997) 
Recently, hundreds of biomedically relevant com-
pounds from cyanobacteria have been reported. 
These include various classes of secondary metabo-
lites such as polyketides, amides, alkaloids, lactones, 
peptides, lipopeptides and compounds of mixed 
biosynthetic origin (Kleinkauf and Dohren, 1997). 
Phormidium valderianum was found to be the most 
active cyanobacteria compared to Calothrix con-
tarenii and Synechococcus sp. The extract from P. 
valderianum was found to be inhibitory against six 
pathogens such as V. parahaemolyticus, V. vulnifi-
cus, V. harveyi, V. alcaligenes, S. epidermidis and 
K. pneumoniae. C. contarenii and Synechococcus 
sp. were active against V. harveyi, V. alcaligenes, 
V. parahaemolyticus and V. alginolyticus. However, 
no antibacterial activity was found in the extract of 
Oscillatoria salina. The antimicrobial activity of 
cyanobacteria against human pathogens is not very 
promising. However, Martins et al. (2008) noted the 
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antibiotic activity of the marine Synechococcus sp. 
against gram-positive bacteria.
Chaetoceros sp. showed moderate activity 
against V. alginolyticus (12 mm) and V. alcaligenes 
(10 mm). The results of the present study (Table 2) 
evidenced that V. alcaligenes and V. alginolyticus are 
more susceptible to all microalgae tested, in agree-
ment with the observations of previous researchers 
who noted vibriocidal activity of microalgae (Navin-
er et al., 1999; Regunathan and Wesley, 2004). 
Antimicrobial activity of marine fauna
It is well known that sponges produce diverse 
secondary metabolites to ward off predators and 
parasites (Pawlik et al., 2002), for competitive ex-
clusion of other sessile life (Becerro et al., 1995) and 
for self protection against infection. The first thera-
peutic agents from the marine environment were 
made from the sponge, Tethya crypta (Bergmann 
and Feeney, 1951). So far more than 5300 differ-
ent natural bioactive products have been discovered 
(Faulkner, 2000, 2001, 2002). Further, the crude ex-
tracts of marine sponges from the Indian coast have 
a high incidence of antibacterial activity against 
shrimp/fish Vibrios (Selvin and Lipton, 2004a). 
In the present study, the methanolic extract of 
Haliclona sp. was active against the bacteria, V. 
parahaemolyticus, V. alginolyticus, B. subtilis, S. 
aureus, S. epidermidis and especially against the 
shrimp pathogens, V. vulnificus and V. alcaligenes. 
This was followed by Acanthella elongata which 
inhibited V. alcaligenes, V. vulnificus, V. harveyi, 
V. alginolyticus and V. parahaemolyticus (Table 
2). It was found that clinical pathogens exhibited 
more resistance to sponge extracts when compared 
to shrimp Vibrios. The results of the present study 
suggest that sponge secondary metabolites could be 
used as an antibiotic substance to manage shrimp 
and human bacterial pathogens. 
Among the 12 molluscans screened, the extracts 
of Turbo bruneus, Tibia curta Cypraea tigris and 
Limnaea sp. showed a moderate inhibitory effect 
against shrimp pathogens (Table 2). The highest 
inhibition values recorded were produced by T. 
bruneus against V. alcaligenes (10 mm), V. para-
haemolyticus (9 mm) V. harveyi (8 mm) and V. al-
ginolyticus (9 mm). Similar activity was reported 
for this taxon against marine biofilm-forming bac-
teria (Ramasamy and Murugan, 2005). In addition, 
only T. bruneus and C. tigris achieved an inhibi-
tion zone against the multiresistant human patho-
gen, B. subtilis (8 mm). The antimicrobial activity 
of molluscan reported here agrees with the results 
of previous studies (Haug et al., 2004; Mercado et 
al., 2005). 
The methanolic extract of the sea cucumber, 
Bohadshia mormorata showed its highest in vitro 
antibacterial activity against the shrimp pathogens, 
V. harveyi (13 mm) and V. vulnificus (11 mm), 
whereas its lowest activity was observed against 
the pathogens, V. alcaligenes (9 mm) and V. algi-
nolyticus (8 mm) (Table 2). Only K. pneumoniae (7 
mm) was sensitive to the methanolic extract of the 
sea cucumber. It was earlier reported by Ridzwan 
et al. (1995), that methanolic extracts of Bohad-
schia argus has no inhibitory activity against bac-
teria, whereas the phosphate buffered saline extract 
has inhibitory activity. As noted by Villasin and 
Pomory (2000), the extract from the body wall of 
the sea cucumber Parastichopus parvimensis had 
antibacterial properties. 
The sea urchin Tripneustes gratilla showed an-
tibacterial activity against V. alcaligenes (11 mm) 
and V. alginolyticus 8 mm. Our results are in agree-
ment with the earlier antibacterial activity of marine 
echinoderm, Paracentrotus lividus against V. algi-
nolyticus (Stabili et al., 1996). Further, it has been 
reported that different body parts of the sea urchin, 
Strongylocentrotus droebachiensis possess antibac-
terial activity (Haug et al., 2002). 
The Cnidaria, Anthopleura sp. showed weak 
activity against the shrimp and human pathogens 
tested. It inhibits the growth of V. alginolyticus (11 
mm) and V. parahaemolyticus (8 mm) (Table 2). 
Similar observations were reported from the benthic 
sea anemone, Stichodactyla haddoni collected from 
the Indian coast against the fish pathogen, Aerom-
onas hydrophila (Williams et al., 2007).
Fractionation and purification of active seaweed 
Falkenbergia-phase of A. taxiformis 
The fraction that exhibited antimicrobial activ-
ity was purified using preparative TLC to obtain a 
single spot with an Rf value of 0.641. The active 
TLC resolved spot was again purified with reverse 
phase HPLC. The HPLC profile showed two peaks 
with retention times (min) of 2.69 and 3.00 respec-
tively at a wavelength of 254 nm (Fig. 2). The eluted 
HPLC peak that retained antimicrobial activity (data 
not shown) was chosen for GC-MS analysis.
294 • A. MANILAL et al.
SCI. MAR., 74(2), June 2010, 287-296. ISSN 0214-8358 doi: 10.3989/scimar.2010.74n2287
Spectrum of the active fraction
The GC-MS chromatogram of Falkenbergia-
phase of the A. taxiformis active fraction is shown 
in Figure 3 and the relative percentage of identified 
compounds is summarized in Table 3. The main 
phycoconstituents of the active fraction were oleic 
acid (51.33%) and n-hexadecanoic acid (42%) fol-
lowed by dodecyl acrylate (1.47%), nitroacetonitrite 
(1.02), 2-nonen-1-ol, (E) (1.02%) and N-decanoic 
acid (0.85%), among others (Table 3). 
In recent years, algal fatty acids have been 
emerging as prominent bioactive lead compounds. 
Falkenbergia-phase has been recognized for its 
many biological activities (Salvador et al., 2007). 
Our results are in accordance with the earlier report 
of Khotimchenko and Vaskovsky (1990) who rec-
ognized the C16, C18, C20 fatty acids to be dominant 
in red algae. Previous studies have already demon-
strated the occurrence of the antibacterial property 
of oleic acid in some plant species (Dilika et al., 
2002) and its antimycobacterial property in red al-
gae (Saravanakumar et al., 2008). In agreement with 
our results Arun kumar et al. (2001) isolated fatty 
acids from the green algae, Enteromorpha flexuosa 
and showed its inhibition against the plant pathogen, 
Xanthomonas oryzae. As stated by Kanias et al. 
(1992), the antibiotic property of algal species could 
be confined to the presence of a mixture of organic 
acids such as oleic, capric, lauric, linoleic, myristic, 
palmitic and stearic acids. 
Mechanism of antibiosis
The MBC/MIC ratios were determined to iden-
tify whether the active principles were bactericidal 
or bacteriostatic compounds. The results of MIC 
and MBC of the active principles from Falkenber-
gia are presented in Table 4. Since the MBC/MIC 
ratios obtained were less than 1, the active principles 
Table 3. – Compounds identified from the active fraction of Falkenbergia-phase of A. taxiformis using GC-MS.
Sl. No Retention time Name of the compound Molecular formula Molecular weight Peak Area%
1 1.36 Nitroacetonitrite C2H2N2O2 86 1.02
2 1.68 Ethanamine,2-(methlthio)- C3H9NS 91 0.39
3 2.28 Pentane,3-methyl- C6H14 86 0.17
4 4.16 1-Hexane,2,5-dimethyl- C8H16 112 0.115 4.60 3-Pentanol, 3-ethyl C7H16O 116 0.17
6 5.48 1-Hexene, 4-Methyl- C7H14 98 0.17
7 6.91 1- Heptyn-4-ol C7H12O 112 0.11
8 9.25 (2S, 3S)-(-)-3-Propyloxiranemethanol C6H12O2 116 0.11
9 10.22 1- Cyclopentyl-2,2-dimethyl-1-propanol C10H20O 156 0.11
10 11.95 N-Decanoic acid C10H20O2 172 0.85
11 13.54 Oxirane,(butoxemethyl) C7H14O2 130 0.17
12 17.64 2-Nonen-1-ol, (E)- C9H18O 142 1.02
13 19.05 N-Hexadecanoic acid C16H32O2 256 42.87
14 20.83 Dodecyl acrylate C15H28O2 240 1.47
15 22.39 Oleic acid C18H34O2 282 51.33
Fig. 2. – HPLC profile of active TLC fraction of Falkenbergia-
phase of A. taxiformis.
Fig. 3. – GC-MS chromatogram of the active fraction of Falkenbergia-phase of A. taxiformis
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can be considered as bactericidal. The most sensi-
tive microorganism to the Falkenbergia extract was 
the shrimp pathogen, V. alcaligenes, which showed 
the highest mean zone of inhibition (33 mm) and the 
lowest MIC (500 µg/ml) and MBC (50 µg/ml) val-
ues. The MIC of the extract against shrimp pathogens 
was 500 µg/ml for V. alginolyticus; 750 µg/ml for 
V. vulnificus, V. harveyi and V. parahaemolyticus; 
750 µg/ml for S. aureus and B. subtilis and 1250 µg/
ml for P. aeruginosa, K. pneumoniae and S. epider-
midis. These variations may be due to the chemical 
nature and quantity of bioactive metabolites present 
in the Falkenbergia extract and their mode of action 
towards different test organisms (Barbour et al., 
2004). 
CONCLUSION
Our results imply that the search for novel bio-
active compounds by screening of different marine 
flora and fauna is an efficient sourcing method. 
Screening tactics based on the ecological knowledge 
of marine organisms are being increasingly deployed 
in the investigation of novel bioactive compounds. 
However, the results presented here indicate that 
only a few marine invertebrates show antimicrobial 
properties compared to the flora examined. Of the 
47 species screened, the red alga, Falkenbergia 
stood out as a potential producer of marine bioactive 
metabolites that inhibit the growth of both shrimp 
Vibrios and multiresistant human pathogens. The 
main bioactive constituents of this alga were inves-
tigated using GC-MS analysis. Bioactivity guided 
purification of the active fraction resulted in the 
preliminary identification of a mixture of volatile 
compounds including fatty acids. This report shows 
the antimicrobial activity of the Falkenbergia-phase 
of A. taxiformis from the Indian coast for the first 
time. The large biomass produced by Falkenbergia 
along the Kollam coast could make exploiting these 
bioactives economically viable for shrimp disease 
management. Our preliminary results also reveal 
that many of these marine organisms produce more 
or less structurally diverse secondary metabolites 
which could be of agrochemical and pharmaceutical 
interest. 
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